“…The clinical factors included: male gender [5,18,32], patient's age [5,18,[32][33][34], body mass index [18], serum tumour markers [18,33], presence of symptoms [18,32], mean duration of symptoms [18,32], non-resectability [35], extent of surgery [5,36], familial occurrence of tumour [37], and multiple primary lesions in a single patient [38,39]. Histopathological factors included: extrapancreatic localization of the main neoplastic mass [40,41], localization of tumour within particular segment of the pancreas [5,18,32], tumour diameter [5,32,42], gross characteristics of tumour (solid, cystic, or mixed) [18,32,43], tumour rupture [43][44][45], lack of a tumour capsule [46] and incomplete capsule [47], capsule invasion [17,18,33,48], invasion into pancreatic parenchyma [17,33,49] or adjacent tissues or organs (invasion of duodenum, spleen, common bile duct, peripancreatic fat) …”